NCT00319696View on ClinicalTrials.gov

Bosentan in Digital Ulcers

PHASE3CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

July 8, 2004

Primary Completion Date

January 22, 2009

Study Completion Date

January 22, 2009

Conditions
Digital Ulcers
Interventions
DRUG

Bosentan 62.5 mg

Bosentan 62.5-mg oral tablets twice daily (b.i.d.) for 4 weeks (initial dose)

DRUG

Bosentan 125 mg

Bosentan 125-mg oral tablets administered b.i.d. (target dose)

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY